Medicines the European Medicines Agency has recommended for use in the European Union on this topic.
Each number has its full source under its own list below.
9 medicines (authorised now). Newest first. Each links to its EMA page.
Active substance: melatonin
Active substance: daridorexant hydrochloride
Active substance: semaglutide
Active substance: pitolisant
Active substance: solriamfetol hydrochloride
Active substance: melatonin
Active substance: tasimelteon
Active substance: liraglutide
Active substance: melatonin
Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.
Worldwide · 2024–2034
View report Digital HealthWorldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report Digital HealthWorldwide · 2024–2034
View report
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
ReadAcuitas market sizes and forecasts are only in our full reports. How we use public data.